Literature DB >> 7527838

Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.

R Lambkin1, L McLain, S E Jones, S L Aldridge, N J Dimmock.   

Abstract

It is not fully understood how antigenic drift of the haemagglutinin of type A influenza virus in man occurs in the presence of the expected polyclonal antibody response to the five antigenic sites, A to E. Here we show that 12% (11/92) of sera from mice which had mounted a secondary immune response to inactivated influenza virus were able to select escape mutants. No escape mutant was selected with serum from nonimmunized mice (0/65). Selection required only a single passage, and escape mutants were identified by their reaction with monoclonal antibodies (MAbs); all but one had altered reactivity at site A. Most of the site A escape mutants (7/10) were conventional in character and did not react in haemagglutination-inhibition (HI) or neutralization assays with the identifying MAb. The HA genes of three of these were part sequenced and had a predicted single amino acid substitution (Gly-144-->Glu) in site A. The other escape mutants (3/10) had a small (2-fold) reduction in HI and neutralization to the site A MAb, but no amino acid substitution in site A. The final mutant was a conventional site B escape mutant. To model antisera which selected escape mutants, we constructed 'pseudo-immune sera' using mixtures of two neutralizing MAbs in which the first MAb was held at a constant high concentration (1000 HIU/ml). Escape mutants could be selected to the first MAb when the titre of the second MAb was reduced to a low but still inhibiting concentration (1 to 3 HIU/ml). Mixtures of three MAbs also selected escape mutants with similar facility provided that the second and third MAbs were reduced to a similar low concentration. Thus it is possible that the ability of an antiserum to select escape mutants is due to the neutralizing antibody response being biased to an epitope/cross-reacting epitopes within a single antigenic site. However, when escape mutants were reacted in HI assay with their selecting antiserum, the maximum difference from the titre with wt virus was 75%. The findings of this study may be relevant to the understanding of antigenic drift in type A human influenza virus, and to immune-driven antigenic variation in other virus infections.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527838     DOI: 10.1099/0022-1317-75-12-3493

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  29 in total

1.  Accumulation of amino acid substitutions promotes irreversible structural changes in the hemagglutinin of human influenza AH3 virus during evolution.

Authors:  Katsuhisa Nakajima; Eri Nobusawa; Alexander Nagy; Setsuko Nakajima
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  Variation of the conserved neutralizing epitope in influenza B virus victoria group isolates in Japan.

Authors:  Naoko Nakagawa; Ritsuko Kubota; Yoshinobu Okuno
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Discovery of the neutralizing epitope common to influenza B virus victoria group isolates in Japan.

Authors:  Naoko Nakagawa; Jun Suzuoki; Ritsuko Kubota; Shinzo Kobatake; Yoshinobu Okuno
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

4.  Cocirculation of antigenic variants and the vaccine-type virus during the 2004-2005 influenza B virus epidemics in Japan.

Authors:  Naoko Nakagawa; Natsumi Higashi; Toshimasa Nakagawa
Journal:  J Clin Microbiol       Date:  2008-12-17       Impact factor: 5.948

5.  Truncation and sequence shuffling of segment 6 generate replication-competent neuraminidase-negative influenza H5N1 viruses.

Authors:  Donata Kalthoff; Susanne Röhrs; Dirk Höper; Bernd Hoffmann; Jessica Bogs; Jürgen Stech; Martin Beer
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

6.  Loss and gain of N-linked glycosylation sites in globular head and stem of HA found in A/H3N2 flu fatal and severe cases during 2013 Tunisia flu seasonal survey.

Authors:  Awatef El Moussi; Mohamed Ali Ben Hadj Kacem; Amine Slim
Journal:  Virus Genes       Date:  2013-10-31       Impact factor: 2.332

7.  Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO. IL-2Rγc KO. NOD).

Authors:  Mirian Mendoza; Angela Ballesteros; Qi Qiu; Luis Pow Sang; Soumya Shashikumar; Sofia Casares; Teodor-D Brumeanu
Journal:  Hum Vaccin Immunother       Date:  2017-12-21       Impact factor: 3.452

8.  In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.

Authors:  W Cleare; R Cherniak; A Casadevall
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

9.  Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines.

Authors:  Silvia Loureiro; Junyuan Ren; Pongsathon Phapugrangkul; Camilo A Colaco; Christopher R Bailey; Holly Shelton; Eleonora Molesti; Nigel J Temperton; Wendy S Barclay; Ian M Jones
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

10.  Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding.

Authors:  David J Allen; Rob Noad; Dhan Samuel; Jim J Gray; Polly Roy; Miren Iturriza-Gómara
Journal:  Virol J       Date:  2009-09-25       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.